// App-Quantinova.ai

CCRG-04 : TARGETING THE CELL-CYCLE EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) TO INCREASE ITS EFFICACY

Researchers

Presenter

  • Paul Slangen

Principal Investigators

  • Basma Elbakary

  • Lotte van Mil

  • Mark de Gooijer

  • Lenno Krenning

  • Bram van den Broek

  • Marjolijn Mertz

  • Olaf van Tellingen

  • Gerben Borst

Medical Centers

  • The Christie, Manchester, United Kingdom

  • The Netherlands Cancer Institute, Amsterdam, Netherlands

  • University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

Drug/Treatment

  • AZD-1775

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved